Recent VBIV News
- Annual Report (10-k) • Edgar (US Regulatory) • 03/13/2023 12:02:30 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 12:01:23 PM
- VBI Vaccines Reports Full Year 2022 Financial Results • Business Wire • 03/13/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/28/2023 06:03:25 PM
- VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat • Business Wire • 02/23/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/15/2023 01:01:54 PM
- VBI Vaccines Announces Presentation of Interim Phase 2 Data Evaluating Combination of VBI-2601 (BRII-179) and BRII-835 for the Treatment of Chronic Hepatitis B • Business Wire • 02/15/2023 01:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:06:14 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:05:25 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:04:34 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:44 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:44 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:20 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/30/2022 10:01:27 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/27/2022 01:02:11 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/08/2022 01:01:18 PM
- VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults • Business Wire • 12/08/2022 01:00:00 PM
- CEPI Boosts ‘Coronavirus X’ Vaccine Search With Expanded VBI Vaccines Deal • Business Wire • 12/06/2022 02:25:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/22/2022 01:00:59 PM
- VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting • Business Wire • 11/22/2022 01:00:00 PM
- VBI Vaccines to Participate in Upcoming Investor Conferences • Business Wire • 11/14/2022 01:00:00 PM
- VBI Vaccines Announces Presentation of Data from Ongoing Phase 2a Study of VBI-1901 at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting • Business Wire • 11/11/2022 01:00:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 01:01:59 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:01:29 PM
- VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update • Business Wire • 11/10/2022 01:00:00 PM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM
Hollywall Entertainment Inc., (OTC:HWAL) Announces the completion of its 2021 and 2020 Audit (s) • HWAL • Mar 24, 2023 12:48 PM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM